Insomnia is a very common disorder that can affect up to 50% of the general population at any given time. Anecdotally, cannabis is frequently reported to promote sleep, however, there are very few studies investigating how cannabis affects the brain during sleep in people with insomnia.

As medical cannabis becomes more readily available, it is imperative that we answer questions around the risks. Our research is contributing to the ongoing policy debate regarding issues such as safety, impairment and detection when driving.

Our preclinical research explores how specific cannabinoids and full-spectrum extracts may treat PTSD, aiming to identify lead compounds and inform the design of future clinical studies for therapeutic development.